医学
甲氨蝶呤
慢性荨麻疹
皮肤病科
内科学
不利影响
氯雷他定
银屑病
药物治疗
重症监护医学
作者
Jaspriya Sandhu,Arushi Kumar,Sunil Gupta
标识
DOI:10.25259/ijdvl_1145_20
摘要
Background Chronic in many cases, has an unsatisfactory response to antihistamines. The current recommendations in do not mention the dose and duration for methotrexate. Aims This study aims to systematically review the use/efficacy of in urticaria. Methods A systematic search in four databases, that is, PubMed/Medline, Cochrane central, Google Scholar and Clinicaltrials.gov was done to identify studies on the use of in using key words methotrexate [MeSH terms] and urticaria or urticaria, chronic or urticaria, spontaneous. Results Nine articles (study participants 127), including three randomized control trials, one prospective interventional trial without control, three retrospective reviews and two case reports, were identified and finally included in the systematic review. There was a paucity of literature and the three randomized control trials did not show any benefit of over antihistamines alone. However, in studies where steroid-dependent cases were given methotrexate, marked benefit was reported with steroid-sparing effect, particularly on dose escalation. Limitations Due to a paucity of published literature on in a meta-analysis could not be done. Conclusion In recalcitrant or steroid-dependent cases, may be a therapeutic agent of interest; however, current evidence does not point to any added advantage in efficacy over antihistamines. More evidence based on larger, well-executed randomized control trials is needed in the future to get more definitive answers.
科研通智能强力驱动
Strongly Powered by AbleSci AI